Ensign Peak Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $255M | Buy |
|
|||||
|
2025
Q1 | $240M | Buy |
|
|||||
|
2024
Q4 | $154M | Buy |
|
|||||
|
2024
Q3 | $135M | Buy |
|
|||||
|
2024
Q2 | $98M | Sell |
|
|||||
|
2024
Q1 | $105M | Sell |
|
|||||
|
2023
Q4 | $241M | Sell |
|
|||||
|
2023
Q3 | $268M | Sell |
|
|||||
|
2023
Q2 | $281M | Buy |
|
|||||
|
2023
Q1 | $297M | Sell |
|
|||||
|
2022
Q4 | $340M | Sell |
|
|||||
|
2022
Q3 | $277M | Buy |
|
|||||
|
2022
Q2 | $167M | Buy |
|
|||||
|
2022
Q1 | $131M | Buy |
|
|||||
|
2021
Q4 | $113M | Sell |
|
|||||
|
2021
Q3 | $139M | Sell |
|
|||||
|
2021
Q2 | $146M | Buy |
|
|||||
|
2021
Q1 | $119M | Buy |
|
|||||
|
2020
Q4 | $91.8M | Buy |
|
|||||
|
2020
Q3 | $66.8M | Sell |
|
|||||
|
2020
Q2 | $96.5M | Sell |
|
|||||
|
2020
Q1 | $112M | Buy |
|
|||||
|
2019
Q4 | $56.9M | Buy |
|